An essential and complete guide for the biotechnology companies operating in Singapore.



New lab to provide customised cancer treatment

The Genome Institute of Singapore (GIS) has launched a new laboratory that will help provide customised, cutting-edge treatment for cancer patients.

The lab - set up in partnership with local healthcare bioanalytic firm Invitrocue - will develop models of cancerous tumours using cells from patients, and utilise tech tools like artificial intelligence and data mining to trawl through genetic ...more

Focus on quality and purity

THE JCS group of companies, which is among the winners of the SME100 awards this year was founded 27 years ago in 1990 by Jason Yeo and includes companies that provide products and solutions for the technology, biotech, renewable energy, aerospace, healthcare and consumer markets.

The focal companies for the award were BioCair, a market-leading non-toxic disinfectant used by hospitals, clinics, ...more

New cancer centre to be built at Biopolis

A new cancer centre will be built at Biopolis, in Buona Vista, and open in stages from next year.

Called the Advanced Medicine Oncology Centre, it will provide imaging, treatment delivery, and clinical informatics technologies for healthcare professionals and researchers.

It is a collaboration between Royal Philips, the Singapore Institute of Advanced Medicine Holdings (SAM), Varian ...more

Science Briefs: Conference on gene mutation

Conference on gene mutation Over 300 international scientists will gather in Singapore to share their latest findings on p53, the most common gene mutation in cancer.

Known as the "guardian of the genome", p53 works as a major tumour suppressor which defends cells in the body from any form of stress, including radiation, preventing them from becoming cancerous.

However, when mutated, ...more

Singapore-based firm on track to commercialise cancer drug


SCIENTISTS are now a step closer to turning cancer patients' own immune cells (T-cells) against the tumours in their bodies - and possibly finding a cure for the dreaded disease.

A Singapore-based biotechnology firm has emerged ahead of the very crowded research field of T-cell immunotherapy, by conducting the world's first US Food and Drug Administration (FDA) Phase Three ...more

Engineering 'good' bacteria to kill bad ones

We are never alone.

Our bodies are in constant cohabitation with microbial cells. The composition of these microbial cells, an ecosystem known as the microbiome, exerts tremendous influence on our health. Just the right mix of bacteria can help to protect us from numerous chronic and acute diseases.

Recent scientific studies have highlighted the association of the microbiome with ...more

Pharma stocks a growing healthcare sub-segment


EVEN though pharmaceuticals is one of the smaller sub-segments in the Singapore Exchange's (SGX's) cluster of healthcare stocks, its year-to-date market cap-weighted average total return of 7.3 per cent is almost double that of the 3.8 per cent generated by the SGX All Healthcare Index - the benchmark for listed healthcare companies here.

The six stocks are: Tianjin ZhongXin ...more

Bayer reports record Asia-Pac sales for 6th straight year on rising, ageing population


GERMAN chemicals giant Bayer is on a high in the Asia-Pacific, reporting record sales for the sixth year running.

Pharmaceuticals sales are up 8.6 per cent at 4.8 billion euros (S$7.25 billion) for 2016. This is more than a quarter of its total sales worldwide, said Claus Zieler, senior vice-president and head of commercial operations at its Asia-Pacific pharmaceutical division.

He ...more

Home-grown blood cancer drug to start patient trials

The developers of home-grown blood cancer drug ETC-206 hope to start trials in August on patients who are in the late stages of the cancer.

The drug, which is orally administered, will be tested on blood cancer patients in groups of three. Clinical trials began last December and will test up to 34 healthy volunteers.

ETC-206 was primarily developed by the Experimental Therapeutics ...more

Singapore-based Acromec secures $8.7m contract from pharmaceutical firm


SPECIALIST engineering services provider Acromec has secured an S$8.7 million contract from a pharmaceutical company. The contract, which is expected to be completed by the third quarter of the financial year ending Sept 30, 2017, involves fitting out production facilities in an extension project in a pharmaceutical plant.

The facilities will occupy three levels connected ...more

New supercomputer transforming research

A new supercomputer in Singapore, much more powerful than anything else in the region, is transforming research and industry here.

Not yet a year old, the machine is already being used to design safer and more cost-effective megastructures, as well as to understand how human genes cause disease. And it has the potential to transform research in many other areas.

Named Aspire 1, ...more

GSK names new Asia-Pacific head of pharmaceuticals


BRITISH pharmaceutical company GlaxoSmithKline has appointed Herv� Gisserot as its head of pharmaceuticals, Asia-Pacific, based in Singapore.

Mr Gisserot will oversee the company's commercial operations and product portfolio within the Asia-Pacific region.

His appointment comes ahead of predicted growth for the industry in the region, which comprises Australia, ...more

Electronics, biomed clusters spur Q4 manufacturing growth


THE electronics and biomedical manufacturing clusters powered the expansion of the manufacturing sector, which grew 6.5 per cent year on year in the final quarter of 2016.

This is a jump from the 1.7 per cent growth in the previous quarter, as shown by advanced estimates of the real gross domestic product (GDP) by the Ministry of Trade and Industry (MTI) on Tuesday.

But ...more